Literature DB >> 7249893

Plasma secretin concentrations and gastric pH in healthy subjects and patients with digestive diseases.

J M Rominger, W Y Chey, T M Chang.   

Abstract

Plasma secretin concentrations were determined in healthy subjects and patients with duodenal ulcer, achlorhydria, and celiac sprue. Mean fasting plasma secretin concentrations in 26 healthy subjects and 26 duodenal ulcer patients were 6.7 +/- 0.5 and 10.2 +/- 1.2 pg/ml, respectively, and were significantly different (P less than 0.02). After ingestion of a standard meat meal, pyloric pH decreased to less than 4.5 within 15 min and plasma secretin concentrations significantly increased in all 52 subjects. In 14 subjects (seven healthy subjects and seven patients with duodenal ulcer), no significant rise in plasma secretin concentration occurred when pyloric pH was maintained at greater than 5.0 by intravenous cimetidine (600 mg) and intragastric antacid. In 10 achlorhydric patients, intragastric pH remained greater than 5.0 after the meal and plasma secretin concentrations did not change. However, plasma secretin concentrations increased significantly when 0.1 N HCl was infused in the stomach (25 mEq/hr) during the postprandial period. In all eight adult patients with celiac disease (seven untreated, one partially treated), pyloric pH remained less than 4.0 after a meal. Postprandial secretin concentrations did not increase significantly in six and showed a transient rise in two. These studies show that (1) plasma secretin concentration increases significantly after meals in healthy subjects and patients with duodenal ulcer; (2) neutralization of gastric acid and the achlorhydric state show no significant postprandial rise in plasma secretin concentration; (3) achlorhydric patients do not have a defect in secretin release in response to acid; and (4) failure of postprandial rise in plasma secretin in patients with celiac disease is attributed to impaired release of secretin and in achlorhydric patients it is attributed to lack of acid secretion.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7249893     DOI: 10.1007/bf01367670

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Plasma levels of secretin in man and dogs: validation of a secretin radioimmunoassay.

Authors:  P L Rayford; P J Curtis; R Fender; J C Thompson
Journal:  Surgery       Date:  1976-06       Impact factor: 3.982

2.  Measurement of gastric functions during digestion of ordinary solid meals in man.

Authors:  J R Malagelada; G F Longstreth; W H Summerskill; V L Go
Journal:  Gastroenterology       Date:  1976-02       Impact factor: 22.682

Review 3.  Radioimmunoassay of gastrointestinal hormones.

Authors:  E Straus
Journal:  Gastroenterology       Date:  1978-01       Impact factor: 22.682

4.  Preparation and specificity of antiserum to synthetic secretin and its use in a radioimmunoassay (RIA).

Authors:  G Boden; W Y Chey
Journal:  Endocrinology       Date:  1973-06       Impact factor: 4.736

5.  Impaired immunoreactive secretin release in coeliac disease.

Authors:  F A O'Connor; J C McLoughlin; K D Buchanan
Journal:  Br Med J       Date:  1977-03-26

6.  Rapid extraction of secretin from plasma by XAD-2 resin and its application in the radioimmunoassay of secretin.

Authors:  H H Tai; W Y Chey
Journal:  Anal Biochem       Date:  1978-07-01       Impact factor: 3.365

7.  Plasma secretin concentrations in fasting and postprandial states in dog.

Authors:  M S Kim; K Y Lee; W Y Chey
Journal:  Am J Physiol       Date:  1979-05

8.  Secretion pattern of secretin in man: regulation by gastric acid.

Authors:  O B Schaffalitzky de Muckadell; J Fahrenkrug
Journal:  Gut       Date:  1978-09       Impact factor: 23.059

9.  Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer.

Authors:  J S Fordtran; J H Walsh
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

10.  Duodenal endocrine cells in adult coeliac disease.

Authors:  K Sjölund; J Alumets; N O Berg; R Håkanson; F Sundler
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

View more
  7 in total

1.  Plasma secretin in response to pure bile salts and endogenous bile in man.

Authors:  S Bondesen; H Christensen; K Lindorff-Larsen; O B Schaffalitzky de Muckadell
Journal:  Dig Dis Sci       Date:  1985-05       Impact factor: 3.199

2.  Plaunotol inhibits postprandial gastrin release by its unique secretin-releasing action in humans.

Authors:  K Shiratori; S Watanabe; T Takeuchi; K Shimizu
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

Review 3.  The physiological roles of secretin and its receptor.

Authors:  Syeda Afroze; Fanyin Meng; Kendal Jensen; Kelly McDaniel; Kinan Rahal; Paolo Onori; Eugenio Gaudio; Gianfranco Alpini; Shannon S Glaser
Journal:  Ann Transl Med       Date:  2013-10

4.  Release of cholecystokinin and exocrine pancreatic secretion in response to an elemental diet in human subjects.

Authors:  S Watanabe; K Shiratori; T Takeuchi; W Y Chey; C H You; T M Chang
Journal:  Dig Dis Sci       Date:  1986-09       Impact factor: 3.199

5.  Plasma secretion and pancreatic secretion in response to liver extract meal with varied pH and exogenous secretin in the dog.

Authors:  W Y Chey; S J Konturek
Journal:  J Physiol       Date:  1982-03       Impact factor: 5.182

6.  Role of endogenous secretin in acid-induced inhibition of human gastric function.

Authors:  J H Kleibeuker; V E Eysselein; V E Maxwell; J H Walsh
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

7.  Secretin is an enterogastrone in humans.

Authors:  C H You; W Y Chey
Journal:  Dig Dis Sci       Date:  1987-05       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.